<DOC>
	<DOCNO>NCT01889290</DOCNO>
	<brief_summary>- Assessment pharmacokinetic parameter daily subcutaneously administer methylnaltrexone 10 evaluable neurointensive care patient . - Quantification methylnaltrexone passage blood-brain-barrier critically ill patient severe cerebral affection . - Observation laxation response methylnaltrexone application relation plasma concentration methylnaltrexone . - Assessing safety daily administer methylnaltrexone neurointensive care patient . - Trial medicinal product</brief_summary>
	<brief_title>Methylnaltrexone Pharmacokinetics Neurointensive Care Patients</brief_title>
	<detailed_description>After administration methylnaltrexone s.c. multiple peripheral blood sample additionally two liquor sample draw dose interval day 1 , 3 , 5 drug administration .</detailed_description>
	<mesh_term>Sufentanil</mesh_term>
	<mesh_term>Methylnaltrexone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Inclusion criterion : hospitalisation neurointensive care unit deep sedation sufentanil dose = 40 mcg/h male female age 18 year old female : negative pregnancy test Ventricular drainage part need therapeutic measure Exclusion criterion : History hypersensitivity methylnaltrexone ( RelistorÂ® ) confirm suspected obstructive ileus factor possibly lead intestinal obstruction ( e.g . intestinal tumor ) increase risk patient localize diffused reduction structural integrity gastrointestinal tract ( e.g . peptic ulcer , acute diverticulitis ) severe hepatic insufficiency ( ChildPugh Class C ) renal impairment ( glomerular filtration rate &lt; 90 ml/min ) without renal replacement therapy severe diarrhea despite high opioid dose participation another study investigational drug within 30 day precede present study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>methylnaltrexone</keyword>
	<keyword>opioid-antagonist</keyword>
	<keyword>Obstipation</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>